SCHEMBL13545936

SCHEMBL13545936

CCCNc1ccc(NC(=O)c2ccccc2NC(=O)c2ccc(Cl)s2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.52
▸ ALDH1A1 P00352 2/20 0.52
▸ HPGD P15428 1/20 0.52
▸ PRSS12 P56730 3/20 0.52
▸ KMT2A Q03164 3/20 0.48
▸ MEN1 O00255 2/20 0.48
▸ LMNA P02545 2/20 0.48
▸ MT-CO2 P00403 1/20 0.48
▸ HTT P42858 1/20 0.48
▸ RECQL P46063 1/20 0.48
▸ MAPT P10636 3/20 0.47
▸ F10 P00742 2/20 0.45
▸ KDM4E B2RXH2 2/20 0.44
▸ GAA P10253 1/20 0.44
▸ TP53 P04637 1/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.44
▸ RXFP1 Q9HBX9 1/20 0.44
▸ ABCG2 Q9UNQ0 4/20 0.43
▸ NPC1 O15118 1/20 0.42
▸ RAB9A P51151 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3614270 0.82 PRSS12 (0.44) SMN1; SMN2ALDH1A1HPGDPRSS12KMT2A
SCHEMBL3622343 0.74 TSHR (0.63) SMN1; SMN2ALDH1A1HPGDKMT2AMEN1
SCHEMBL24489089 0.74 ALDH1A1 (0.62) SMN1; SMN2ALDH1A1HPGDPRSS12KMT2A
SCHEMBL29694087 0.74 ALDH1A1 (0.62) SMN1; SMN2ALDH1A1HPGDPRSS12KMT2A
SCHEMBL12040651 0.74 POLB (0.44) SMN1; SMN2ALDH1A1HPGDPRSS12MAPT
SCHEMBL9283635 0.73 NPC1 (0.63) SMN1; SMN2ALDH1A1HPGDPRSS12KMT2A
SCHEMBL8236138 0.72 F10 (0.55) SMN1; SMN2ALDH1A1HPGDPRSS12KMT2A
SCHEMBL3613996 0.71 F10 (0.51) SMN1; SMN2ALDH1A1HPGDPRSS12KMT2A
SCHEMBL3604203 0.71 PRSS12 (0.47) SMN1; SMN2ALDH1A1HPGDPRSS12KMT2A
SCHEMBL3613707 0.70 PRSS12 (0.43) SMN1; SMN2ALDH1A1HPGDPRSS12KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100004292-A1 Iminooxazolidine Derivatives and Their Use BAYER HEALTHCARE AG (DE) 2010-01-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100004292-A1 Iminooxazolidine Derivatives and Their Use PPOX, XDH, PNPO SMN1; SMN2 1729/4885ALDH1A1 906/4885HPGD 43/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback